chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: red and swollen at the injection site; Red and swollen at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE ERYTHEMA (red and swollen at the injection site) and VACCINATION SITE SWELLING (Red and swollen at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZ1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included VITAMINS NOS, ESTRADIOL, PROGESTERONE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site). On 17-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red and swollen at the injection site) and VACCINATION SITE SWELLING (Red and swollen at the injection site). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site) had resolved and VACCINATION SITE ERYTHEMA (red and swollen at the injection site) and VACCINATION SITE SWELLING (Red and swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received the vaccine nine days ago, and had swelling at the injection site but they resolved after three days She woke up today, and it was red and swollen at the injection site.  The treatment information included ice pack.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: low grade fever; experienced severe headache; sore arm; body aches; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (low grade fever), HEADACHE (experienced severe headache), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches) and FATIGUE (fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 015M20A) for COVID-19 vaccination.     Concomitant products included SUMATRIPTAN for Migraine, ATORVASTATIN and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (low grade fever), HEADACHE (experienced severe headache), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches) and FATIGUE (fatigue). At the time of the report, PYREXIA (low grade fever), HEADACHE (experienced severe headache), PAIN IN EXTREMITY (sore arm), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had not experienced any adverse events after first dose. Treatment information were not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Feeling of body temperature change
Clinical narrative: felt hot chills; dizzy; hard time exhaling; tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (felt hot chills), DIZZINESS (dizzy), DYSPNOEA (hard time exhaling) and FATIGUE (tired) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery in June 2020.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Feb-2021, the patient experienced FATIGUE (tired). On 10-Mar-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (felt hot chills), DIZZINESS (dizzy) and DYSPNOEA (hard time exhaling). The patient was treated with DULOXETINE on 27-Feb-2021 at an unspecified dose and frequency. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (felt hot chills), DIZZINESS (dizzy), DYSPNOEA (hard time exhaling) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Frostbite, Hyperhidrosis
Clinical narrative: spells of dizziness; sweats; her hands are frozen; fatigued; pain on the injection site; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued) and VACCINATION SITE PAIN (pain on the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued), VACCINATION SITE PAIN (pain on the injection site) and CHILLS (chills). At the time of the report, DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued), VACCINATION SITE PAIN (pain on the injection site) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: spells of dizziness; sweats; her hands are frozen; fatigued; pain on the injection site; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued) and VACCINATION SITE PAIN (pain on the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued), VACCINATION SITE PAIN (pain on the injection site) and CHILLS (chills). At the time of the report, DIZZINESS (spells of dizziness), HYPERHIDROSIS (sweats), FROSTBITE (her hands are frozen), FATIGUE (fatigued), VACCINATION SITE PAIN (pain on the injection site) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No specific follow-up information recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: sore arm/ arm hurting bad; Couple hours when checked had fever 97.1 degree; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm/ arm hurting bad) and PYREXIA (Couple hours when checked had fever 97.1 degree) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A0A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to codeine), Drug allergy (allergic to aspirin), Chronic kidney disease stage 3, Anxiety and Depression.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (sore arm/ arm hurting bad) and PYREXIA (Couple hours when checked had fever 97.1 degree). At the time of the report, PAIN IN EXTREMITY (sore arm/ arm hurting bad) and PYREXIA (Couple hours when checked had fever 97.1 degree) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Pyrexia: 97.1 (High) 97.1.         concomitant medication was not provided. Treatment information was not provided.    This case was linked to MOD-2021-048252 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate decreased, Oral herpes
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of decreased heart rate (her pulse has been low more often), oral herpes (9 cold sores since the vaccine) and fatigue in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006M20A) for COVID-19 immunization. No medical history provided. On Feb 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. February 2021, patient experienced ORAL HERPES (9 cold sores since the vaccine). On an unknown date, patient experienced decreased heart rate (her pulse has been low more often) and fatigue. At the time of the report, decreased heart rate (her pulse has been low more often), oral herpes (9 cold sores since the vaccine) and fatigue: not resolved/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The patient reported wearing an event monitor from Mar 9, 2021 to Mar 23, 2021. Concomitant medication and treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node on her neck; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (Swollen lymph node on her neck) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph node on her neck). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) at a dose of UNK dosage form. At the time of the report, LYMPHADENOPATHY (Swollen lymph node on her neck) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: blood in their urine; This spontaneous case was reported by an other and describes the occurrence of BLOOD URINE PRESENT (blood in their urine) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (blood in their urine). At the time of the report, BLOOD URINE PRESENT (blood in their urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: waves of nausea; This spontaneous case was reported by a non-health professional and describes the occurrence of NAUSEA (waves of nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ASCORBIC ACID (VITAMINS C) for an unknown indication.    On 05-Mar-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced NAUSEA (waves of nausea). At the time of the report, NAUSEA (waves of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by reporter..
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: small red area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (small red area at the injection site) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (small red area at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (small red area at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-048884 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048884:Crosslinked case
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Very large red spot at vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Very large red spot at vaccination site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Very large red spot at vaccination site). At the time of the report, VACCINATION SITE ERYTHEMA (Very large red spot at vaccination site) outcome was unknown. Unknown          Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Insomnia, Lip blister, Nasal congestion
Clinical narrative: congestion; fever blisters on lip; nose is constantly running; no sleep in 4 days; sick; slight fevers every night; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), INSOMNIA (no sleep in 4 days) and ILLNESS (sick) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On an unknown date, the patient experienced NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), INSOMNIA (no sleep in 4 days), ILLNESS (sick), PYREXIA (slight fevers every night) and HEADACHE (headache).   The patient was treated with LEVOFLOXACIN for Sickness, at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), ILLNESS (sick), PYREXIA (slight fevers every night) and HEADACHE (headache) had not resolved and INSOMNIA (no sleep in 4 days) had resolved.      Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-048206 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: congestion; fever blisters on lip; nose is constantly running; no sleep in 4 days; sick; slight fevers every night; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), INSOMNIA (no sleep in 4 days) and ILLNESS (sick) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On an unknown date, the patient experienced NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), INSOMNIA (no sleep in 4 days), ILLNESS (sick), PYREXIA (slight fevers every night) and HEADACHE (headache).   The patient was treated with LEVOFLOXACIN for Sickness, at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (congestion), LIP BLISTER (fever blisters on lip), RHINORRHOEA (nose is constantly running), ILLNESS (sick), PYREXIA (slight fevers every night) and HEADACHE (headache) had not resolved and INSOMNIA (no sleep in 4 days) had resolved.      Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-048206 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Burning sensation, Crying, Illness
Clinical narrative: Hurting in fingers; Extremely sick; Burning; Crying out loud; pain; Swollen arm; Left arm started hurting badly; Pain from the shoulders running down her hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke in March 2015. Concurrent medical conditions included Thyroid disorder and Hypertension.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud), PAIN (pain), VACCINATION SITE SWELLING (Swollen arm), AXILLARY PAIN (Left arm started hurting badly) and ARTHRALGIA (Pain from the shoulders running down her hand). At the time of the report, PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud), PAIN (pain), VACCINATION SITE SWELLING (Swollen arm), AXILLARY PAIN (Left arm started hurting badly) and ARTHRALGIA (Pain from the shoulders running down her hand) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications included thyroid medications, medications for blood thinner, high blood pressure medications. The patient did not receive any treatment.   Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vaccination site swelling
Clinical narrative: Hurting in fingers; Extremely sick; Burning; Crying out loud; pain; Swollen arm; Left arm started hurting badly; Pain from the shoulders running down her hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke in March 2015. Concurrent medical conditions included Thyroid disorder and Hypertension.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud), PAIN (pain), VACCINATION SITE SWELLING (Swollen arm), AXILLARY PAIN (Left arm started hurting badly) and ARTHRALGIA (Pain from the shoulders running down her hand). At the time of the report, PAIN IN EXTREMITY (Hurting in fingers), ILLNESS (Extremely sick), BURNING SENSATION (Burning), CRYING (Crying out loud), PAIN (pain), VACCINATION SITE SWELLING (Swollen arm), AXILLARY PAIN (Left arm started hurting badly) and ARTHRALGIA (Pain from the shoulders running down her hand) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications included thyroid medications, medications for blood thinner, high blood pressure medications. The patient did not receive any treatment.   Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness on Injection Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on Injection Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on Injection Arm). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on Injection Arm) had resolved.            Concomitant medications were not reported.   This case was linked to MOD21-039600, MOD21-056083 (E2B Linked Report).; Sender's Comments:  MOD21-039600:Cross linked cases with patient case MOD21-056083:Cross linked cases with patient case
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20a and 013M20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported). Concomitant products included MELOXICAM (MOBIC), PARACETAMOL (TYLENOL), METFORMIN, AMLODIPINE and NABUMETONE for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Patient used Benadryl cream as a treatment medication.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Sore arm/ Arm hurting bad; Couple hours when checked had fever 97.1 degree; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm/ Arm hurting bad), PYREXIA (Couple hours when checked had fever 97.1 degree) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for an unknown indication.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm/ Arm hurting bad), PYREXIA (Couple hours when checked had fever 97.1 degree) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm/ Arm hurting bad), PYREXIA (Couple hours when checked had fever 97.1 degree) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.           No Concomitant medication were reported. No treatment information was reported.        This case was linked to MOD-2021-048225 (Patient Link).   Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic, Vaccination site swelling
Clinical narrative: it was itchy; it was itchy, red; it was itchy, red and swollen; Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (it was itchy), RASH ERYTHEMATOUS (it was itchy, red), VACCINATION SITE SWELLING (it was itchy, red and swollen) and RASH (Rash) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included PRIMIDONE, BACLOFEN, PROPRANOLOL and TRAZODONE for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced RASH (Rash). On an unknown date, the patient experienced RASH PRURITIC (it was itchy), RASH ERYTHEMATOUS (it was itchy, red) and VACCINATION SITE SWELLING (it was itchy, red and swollen). At the time of the report, RASH PRURITIC (it was itchy), RASH ERYTHEMATOUS (it was itchy, red) and VACCINATION SITE SWELLING (it was itchy, red and swollen) outcome was unknown and RASH (Rash) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The rash was of the size of palm of his hand. It gradually faded but was still visible. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-048290 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up- Email id updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048290:Second dose case
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: area around the injection site has rash; injection site started itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site started itching) and VACCINATION SITE RASH (area around the injection site has rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (injection site started itching). On 14-Mar-2021, the patient experienced VACCINATION SITE RASH (area around the injection site has rash). The patient was treated with CORTISONE for Vaccination site pruritus and Vaccination site rash, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (injection site started itching) and VACCINATION SITE RASH (area around the injection site has rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: sore arm; Back aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and BACK PAIN (Back aches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol. Concomitant products included SIMVASTATIN for High cholesterol.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and BACK PAIN (Back aches). At the time of the report, PAIN IN EXTREMITY (sore arm) and BACK PAIN (Back aches) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-224924 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Interchange of vaccine products
Clinical narrative: 1st dose Pfizer, 2nd dose Moderna; "every joint in her aunt's body was hurting"; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st dose Pfizer, 2nd dose Moderna) and ARTHRALGIA ("every joint in her aunt's body was hurting") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st dose Pfizer, 2nd dose Moderna) and ARTHRALGIA ("every joint in her aunt's body was hurting"). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (1st dose Pfizer, 2nd dose Moderna) and ARTHRALGIA ("every joint in her aunt's body was hurting") had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Reportedly, the patient was in her 70's.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-048805 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048805:Crosslinked case
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red area at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red area at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area at the site of injection). At the time of the report, VACCINATION SITE ERYTHEMA (red area at the site of injection) had not resolved.            Concomitant medications were not reported. Treatment information was not reported.   This case was linked to MOD-2021-048244 (Patient Link).
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis, Erythema
Clinical narrative: skin reaction on her face that is red and inflamed; skin reaction on her face that is red and inflamed; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (skin reaction on her face that is red and inflamed) and DERMATITIS (skin reaction on her face that is red and inflamed) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ERYTHEMA (skin reaction on her face that is red and inflamed) and DERMATITIS (skin reaction on her face that is red and inflamed). At the time of the report, ERYTHEMA (skin reaction on her face that is red and inflamed) and DERMATITIS (skin reaction on her face that is red and inflamed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Mass, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: pain in my neck; neck there was a swollen, reddish lump near the chest bone on the right side; neck there was a swollen, reddish lump near the chest bone on the right side; neck there was a swollen, reddish lump near the chest bone on the right side; fever; sleepy; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm), NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side) and ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever). On 16-Mar-2021, the patient experienced NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side), ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) and MASS (neck there was a swollen, reddish lump near the chest bone on the right side). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. On 15-Mar-2021, PYREXIA (fever) had resolved. At the time of the report, SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm), NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side), ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) and MASS (neck there was a swollen, reddish lump near the chest bone on the right side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use included unspecified high blood pressure medication.  Reportedly, next to the patient's lump, she has a ball that upon touching moves inside. The patient stated that she is not going for the second dose.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Swelling
Clinical narrative: pain in my neck; neck there was a swollen, reddish lump near the chest bone on the right side; neck there was a swollen, reddish lump near the chest bone on the right side; neck there was a swollen, reddish lump near the chest bone on the right side; fever; sleepy; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm), NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side) and ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever). On 16-Mar-2021, the patient experienced NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side), ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) and MASS (neck there was a swollen, reddish lump near the chest bone on the right side). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. On 15-Mar-2021, PYREXIA (fever) had resolved. At the time of the report, SOMNOLENCE (sleepy), PAIN IN EXTREMITY (pain in arm), NECK PAIN (pain in my neck), SWELLING (neck there was a swollen, reddish lump near the chest bone on the right side), ERYTHEMA (neck there was a swollen, reddish lump near the chest bone on the right side) and MASS (neck there was a swollen, reddish lump near the chest bone on the right side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use included unspecified high blood pressure medication.  Reportedly, next to the patient's lump, she has a ball that upon touching moves inside. The patient stated that she is not going for the second dose.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: COVID ARM; Itchiness; Red Area; Swelling; Fever of 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever of 102 degrees) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever of 102 degrees). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN at an unspecified dose and frequency. On 14-Mar-2021, PYREXIA (Fever of 102 degrees) had resolved. At the time of the report, VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 102 °F (High) 102.         No concomitant medications were reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: COVID ARM; Itchiness; Red Area; Swelling; Fever of 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever of 102 degrees) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever of 102 degrees). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN at an unspecified dose and frequency. On 14-Mar-2021, PYREXIA (Fever of 102 degrees) had resolved. At the time of the report, VACCINATION SITE REACTION (COVID ARM), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Area) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 102 °F (High) 102.         No concomitant medications were reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Sensitive skin, Vaccination site erythema, Vaccination site induration, Vaccination site rash
Clinical narrative: Sensitive to touch; Couple spots were tender; Rash on right arm; Very red; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (Sensitive to touch), VACCINATION SITE INDURATION (Couple spots were tender), VACCINATION SITE RASH (Rash on right arm) and VACCINATION SITE ERYTHEMA (Very red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031L20A) for COVID-19 vaccination.     Concomitant products included PRIMIDONE, BACLOFEN, PROPRANOLOL and TRAZODONE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced SENSITIVE SKIN (Sensitive to touch), VACCINATION SITE INDURATION (Couple spots were tender) and VACCINATION SITE ERYTHEMA (Very red). 13-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash on right arm). The patient was treated with CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, SENSITIVE SKIN (Sensitive to touch), VACCINATION SITE INDURATION (Couple spots were tender), VACCINATION SITE RASH (Rash on right arm) and VACCINATION SITE ERYTHEMA (Very red) outcome was unknown.            Treatment details included use of ice pack and antihistamines.    This case was linked to US-MODERNATX, INC.-MOD-2021-048253 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up - Email id updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-048253:Crosslinked with dose 1
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache, left side of head bothering me; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache, left side of head bothering me) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (headache, left side of head bothering me). The patient was treated with NAPROXEN SODIUM (ALEVE) in March 2021 for Headache, at a dose of 1 dosage form. At the time of the report, HEADACHE (headache, left side of head bothering me) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Decreased appetite, Headache, Myalgia, Pyrexia
Clinical narrative: loss of appetite; severe headache; soreness; fever of 102; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), HEADACHE (severe headache), MYALGIA (soreness), PYREXIA (fever of 102) and ARTHRALGIA (joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite), HEADACHE (severe headache), MYALGIA (soreness), PYREXIA (fever of 102) and ARTHRALGIA (joint pain). At the time of the report, DECREASED APPETITE (loss of appetite), HEADACHE (severe headache), MYALGIA (soreness), PYREXIA (fever of 102) and ARTHRALGIA (joint pain) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), AMLODIPINE and ATORVASTATIN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was provided.